PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Diabetes and Endocrinology, Sheffield Teaching Hospitals, Sheffield, UK; Department of Oncology and Metabolism, The Medical School, The University of Sheffield, Sheffield, UK.\', \'Department of Diabetes and Endocrinology, Sheffield Teaching Hospitals, Sheffield, UK; Department of Infection, Immunity and Cardiovascular Disease, The Medical School, The University of Sheffield, Sheffield, UK.\', \'Department of Diabetes and Endocrinology, Sheffield Teaching Hospitals, Sheffield, UK.\', \'Department of Diabetes and Endocrinology, Sheffield Teaching Hospitals, Sheffield, UK; Department of Oncology and Metabolism, The Medical School, The University of Sheffield, Sheffield, UK. Electronic address: j.elliott@sheffield.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0168-8227(21)00315-610.1016/j.diabres.2021.108955
?:doi
?:hasPublicationType
?:journal
  • Diabetes research and clinical practice
is ?:pmid of
?:pmid
?:pmid
  • 34273452
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.538
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all